COMMUNIQUÉS West-GlobeNewswire

DLT Resolution Provides Critical Voice and Data Services to World Wide Logistics Services
06/03/2019
Las Vegas, NV, March 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- DLT Resolution Inc. (OTC: DLTI), a Distributed Ledger Technology (“Blockchain”) Voice and Data and Information Technology company, is pleased to [...]
Marrone Bio Innovations to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 14th at 4:30 p.m. Eastern Time
06/03/2019
DAVIS, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in smart biopesticide and plant health solutions, will release financial results for the [...]
Vaccinex, Inc. to Present Data on Its Anti-SEMA4D Compound at the American Association for Cancer Research Annual Meeting 2019
06/03/2019
ROCHESTER, N.Y., March 06, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases [...]
Homology Medicines to Present at Cowen Healthcare Conference
06/03/2019
BEDFORD, Mass., March 06, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Company management will present at the Cowen and Company 39th Annual [...]
PSIQ Files Amendment # 1 to Form S-1 as the Next Step to Becoming an SEC Reporting Issuer and Uplisting to OTCQB
06/03/2019
SUNRISE, Fla., March 06, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) is pleased to announce the filing of amendment # 1 to the Registration Statement on Form S-1 with the U.S. Securities and [...]
Evoke Pharma Reports Fourth Quarter and Full Year 2018 Financial Results and FDA Communication
06/03/2019
Recently received multi-disciplinary review (DR) letter from U.S. Food and Drug Administration (FDA) for Gimoti™ 505(b)(2) New Drug Application (NDA) April 1, 2019 Prescription Drug User Fee Act (PDUFA) date maintained [...]
Exactus Places $1 Million Purchase Order for CBD Products to Accelerate Near Term Growth
06/03/2019
GLEN ALLEN, Va., March 06, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) , a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, today announced it had placed an initial purchase [...]
Hemispherx Biopharma Announces $5.3 Million in Expected Gross Proceeds from Recently Expired Rights Offering
06/03/2019
OCALA, Fla., March 06, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) (“Hemispherx” or the “Company”), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical [...]
SATO America Launches the New Standard in Healthcare Printing Solutions
06/03/2019
CHARLOTTE, N.C., March 06, 2019 (GLOBE NEWSWIRE) -- SATO America, a leading provider of barcode and RFID application solutions has launched the WS2 direct thermal desktop printer. Setting the new standard in 2-inch [...]
Genocea to Present at the Cowen & Company 39th Annual Health Care Conference
06/03/2019
CAMBRIDGE, Mass., March 06, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that Chip Clark, president and [...]
Galectin Therapeutics Releases Richard E. Uihlein’s Open Letter to Stockholders
06/03/2019
NORCROSS, Ga., March 06, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today released this open letter to stockholders written [...]
Galectin Therapeutics Files Registration Statement for Stockholder Rights Offering of Common Stock and Warrants
06/03/2019
Richard E. Uihlein, Board Chair, expresses interest in investing $20.0 million in the Rights Offering NORCROSS, Ga., March 06, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of [...]
Arise Austin Medical Center and The Hospital at Westlake Medical Center select Allscripts Sunrise
06/03/2019
Texas organizations choose Allscripts Sunrise™ for robust EHR with a single patient record CHICAGO, March 06, 2019 (GLOBE NEWSWIRE) -- Arise Austin Medical Center, located in Austin, TX and The Hospital at Westlake [...]
Galectin Therapeutics Reports Fiscal 2018 Financial Results and Provides Business Update
06/03/2019
Planning for Phase 3 clinical trial (NASH-RX) nearing completion for GR-MD-02, the first drug to show positive results in a clinical trial in patients with compensated NASH cirrhosis NORCROSS, Ga., March 06, 2019 (GLOBE [...]
Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia
06/03/2019
Interim Data Update from Phase 2 Study Demonstrates Meaningful Clinical Improvement with Excellent Patient Safety Profile Company Provides Clinical Development Plan with Pathways to Registration HOUSTON, March 06, 2019 [...]
Tabula Rasa HealthCare Appoints New Member to its Board of Directors
06/03/2019
Rear Admiral Pamela Schweitzer, PharmD Joins Board of Medication Safety Company MOORESTOWN, N.J., March 06, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) , a healthcare technology company [...]
Dose Response of Beta-Blockers in Adrenergic Receptor Polymorphism Genotypes Paper Published in Circulation: Genomic and Precision Medicine
06/03/2019
WESTMINSTER, Colo., March 06, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]
IRIDEX to Present at the 31st Annual Roth Conference
06/03/2019
MOUNTAIN VIEW, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to present at the upcoming 31 st Annual Roth Conference in Orange County, CA. Management is [...]
CymaBay Announces Pricing of Public Offering of Common Stock
06/03/2019
NEWARK, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients [...]

Pages